Despite excellent DTaP coverage rates in children and Tdap coverage rates in adolescents, survey data suggest that only about 17% of adults have ever received a Tdap booster dose.5 Pertussis remains endemic throughout the United States, and outbreaks continue to be described highlighting the importance of maintaining high coverage rates in children and adolescents, making sure mother’s are re-immunized during each pregnancy, and working on improving coverage rates in adults. Provider recommendation remains the most impactful method to improve immunization rates, including Tdap.6

Joseph Domachowske, MD, is Professor of Pediatrics and Professor of Microbiology and Immunology at the State University of New York Upstate Medical Center in Syracuse, NY. His research interests include the prevention and treatment of childhood respiratory infections, including involvement in many clinical vaccine trials.

References


Continue Reading

  1. Matoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.Clin Microbiol Rev 2005; 18: 326-82.
  2. Bisgard KM, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985-989.
  3. Halperin SA, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program–Active (IMPACT). Clin Infect Dis 1999; 28: 1238-43.
  4. Bonville CA, et al. Vaccine attitudes and practices among obstetric providers in New York State following the recommendation for pertussis vaccination during pregnancy.Hum Vaccine Immunother 2015;in press.
  5. Williams WW, et al. Vaccination coverage among adults, excluding influenza vaccination – United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64:95-102.
  6. Suryadevara M, et al. Pertussis vaccine for adults: Knowledge, attitudes, and vaccine receipt among adults with children in the household.Vaccine 2014;32:7000-4.